Point72 (DIFC)’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,089
Closed -$24.8K 1630
2025
Q1
$24.8K Buy
2,089
+510
+32% +$7.93K ﹤0.01% 1322
2024
Q4
$24.3K Buy
1,579
+1,559
+7,795% +$20.2K ﹤0.01% 1231
2024
Q3
$224 Sell
20
-5,990
-100% -$57.4K ﹤0.01% 1358
2024
Q2
$32.4K Buy
+6,010
New +$34.8K ﹤0.01% 1164

Other funds holding CLPT

Point72 (DIFC)'s CLPT Position: Q2 2025 in Review

Point72 (DIFC) sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 2,089 shares — an estimated $24.8K sold.

Point72 (DIFC) first reported a position in CLPT in Q2 2024 and held it in 4 quarters. The position peaked at $32.4K in Q2 2024. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

  • Point72 (DIFC) reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 2,089 ClearPoint Neuro shares in Q2 2025, an estimated $24.8K.
  • Point72 (DIFC) first reported a position in ClearPoint Neuro in Q2 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s ClearPoint Neuro position peaked at $32.4K in Q2 2024.
  • 96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.